Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that are activated by fatty acids and their derivatives. The peroxisome proliferator-activated receptors (PPARs) belong to the ligand-inducible nuclear hormone receptor superfamily including three major members: PPARα (also called NR1C1), PPARβ/δ (also called NR1C2), and PPARγ (also called NR1C3). The three subtypes show different expression patterns in vertebrates.
Despite several similarities, each PPAR isoform shows specific functions likely due to different biochemical properties, variable tissue distribution, and differential responses to different ligands. Each of them is encoded in a separate gene and binds fatty acids and eicosanoids.
PPARα plays a role in the clearance of circulating or cellular lipids via the regulation of gene expression involved in lipid metabolism in liver and skeletal muscle. PPAR2α is highly expressed in liver, skeletal muscle, kidney, heart and vascular wall, and relatively low in fat and cartilage.
PPARβ/δ is involved in lipid oxidation and cell proliferation. PPARβ is highly expressed in the brain, stomach and colon.
PPARγ promotes adipocyte differentiation to enhance blood glucose uptake. PPAR gamma was expressed in mammalian adipose tissue, vascular smooth muscle tissue and myocardial tissue.
PPAR transcriptional activity can be modulated through a nongenomic cross talk with phosphatases and kinases, including ERK1/2, p38-MAPK, PKA, PKC, AMPK, and GSK3. PPARs can form heterodimers with retinoid X receptor (RXR) modulating the expression of genes involved in lipid metabolism, adipogenesis, maintenance of metabolic homeostasis, and inflammation and inducing also anticancer effects in a variety of human tumors.
PPARs is an important target of human metabolism-related diseases, and it is involved in regulating energy metabolism, cell differentiation and inflammatory response of peroxidase body proliferation. It is related to many pathophysiological processes such as obesity, insulin resistance, hypertension, T2DM, ankylosing spondylitis (AS) and tumor.
|RXRG||RXRG Antibody||RXRG Protein||RXRG cDNA||RXRG ELISA Kit|
|SCD||SCD Antibody||SCD Protein||SCD cDNA||SCD ELISA Kit|
|SCD5||SCD5 Antibody||SCD5 Protein||SCD5 cDNA||SCD5 ELISA Kit|
|SCP2||SCP2 Antibody||SCP2 Protein||SCP2 cDNA||SCP2 ELISA Kit|
|SLC27A1||SLC27A1 Antibody||SLC27A1 Protein||SLC27A1 cDNA||SLC27A1 ELISA Kit|
|SLC27A2||SLC27A2 Antibody||SLC27A2 Protein||SLC27A2 cDNA||SLC27A2 ELISA Kit|
|SLC27A4||SLC27A4 Antibody||SLC27A4 Protein||SLC27A4 cDNA||SLC27A4 ELISA Kit|
|SLC27A5||SLC27A5 Antibody||SLC27A5 Protein||SLC27A5 cDNA||SLC27A5 ELISA Kit|
|SLC27A6||SLC27A6 Antibody||SLC27A6 Protein||SLC27A6 cDNA||SLC27A6 ELISA Kit|
|SORBS1||SORBS1 Antibody||SORBS1 Protein||SORBS1 cDNA||SORBS1 ELISA Kit|
|UBC||UBC Antibody||UBC Protein||UBC cDNA||UBC ELISA Kit|
|UCP1||UCP1 Antibody||UCP1 Protein||UCP1 cDNA||UCP1 ELISA Kit|